Acetylshikonin Inhibits Human Pancreatic PANC-1 Cancer Cell Proliferation by Suppressing the NF-κB Activity.

Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene (1999) 13.46

Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol (2009) 3.67

Natural products for cancer prevention: a global perspective. Pharmacol Ther (2003) 2.01

NF-kappaB as a potential molecular target for cancer therapy. Biofactors (2007) 1.93

Pancreatic cancer: overview of descriptive epidemiology. Mol Carcinog (2012) 1.38

Cancer prevention by natural carotenoids. Biofactors (2000) 1.26

Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101. Mol Cancer Ther (2007) 1.11

Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis. Eur J Cancer (2008) 1.10

The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy. Sci Rep (2013) 1.03

Shikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cells. Evid Based Complement Alternat Med (2012) 1.02

Yuwen02f1 suppresses LPS-induced endotoxemia and adjuvant-induced arthritis primarily through blockade of ROS formation, NFkB and MAPK activation. Biochem Pharmacol (2012) 0.98

Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo. Mol Carcinog (2013) 0.97

Role of diet modification in cancer prevention. Biofactors (2000) 0.94

Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression? Front Pharmacol (2013) 0.92

A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion. Oncotarget (2015) 0.89

Inhibitory effect of acetylshikonin on human gastric carcinoma cell line SGC-7901 in vitro and in vivo. World J Gastroenterol (2009) 0.87

PKC 412 small-molecule tyrosine kinase inhibitor: single-compound therapy for pancreatic cancer. Cancer (2007) 0.86

Delphinidin suppresses PMA-induced MMP-9 expression by blocking the NF-κB activation through MAPK signaling pathways in MCF-7 human breast carcinoma cells. J Med Food (2014) 0.83

A new EGFR inhibitor induces apoptosis in colon cancer cells. Biochem Biophys Res Commun (2007) 0.83

Acetylshikonin induces apoptosis of hepatitis B virus X protein-expressing human hepatocellular carcinoma cells via endoplasmic reticulum stress. Eur J Pharmacol (2014) 0.81